Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma

Replication conditional oncolytic human adenovirus has long been considered a promising biological therapeutic to target high-grade gliomas (HGG), a group of essentially lethal primary brain cancer. The last decade has witnessed initiation and some completion of a number of Phase I and II clinical i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiyokawa, Juri, Wakimoto, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817710/
https://www.ncbi.nlm.nih.gov/pubmed/31750274
http://dx.doi.org/10.2147/OV.S196403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817710/
https://www.ncbi.nlm.nih.gov/pubmed/31750274
http://dx.doi.org/10.2147/OV.S196403

Ejemplares similares